Nitinol versus steel partially covered self-expandable metal stent for malignant distal biliary obstruction: a randomized trial

Background and study aims: Covered nitinol alloy self-expandable metal stents (SEMSs) have been developed to overcome the shortcomings of steel SEMS in patients with malignant biliary obstruction. In a randomized, multicenter trial, we compared stent patency, patient survival, and adverse events in patients with partly covered stents made from steel or nitinol.

Patients and methods: A total of 400 patients with unresectable distal malignant biliary obstruction were randomized at endoscopic retrograde cholangiopancreatography (ERCP) to insertion of a steel or nitinol partially covered SEMS, with 200 patients in each group. The primary outcome was confirmed stent failure during 300 days of follow-up. 

Results: At 300 days, the proportion of patients with patent stents was 77 % in the steel group, compared with 89 % in the nitinol group (P = 0.01). Confirmed stent failure occurred more often in the steel SEMS group compared with the nitinol SEMS group, in 30 versus 14 patients (P = 0.02). Stent migration occurred in 13 patients in the steel group and in 3 patients in the nitinol group (P = 0.01). Median patient survival (secondary outcome) was 137 days and 120 days in the steel SEMS and nitinol SEMS groups, respectively (P = 0.59).

Conclusions: The nitinol SEMS showed longer patency time, and the nitinol group had fewer patients with stent failure, compared with the steel SEMS group. We could not detect any differences between the two groups regarding survival time, and regarding adverse event rate.

Clinical trial registration : NCT 00980889

• References

• 1 Stern N, Sturgess R. Endoscopic therapy in the management of malignant biliary obstruction. Eur J Surg Oncol 2008; 34: 313-317
• 2 Kaassis M, Boyer J, Dumas R et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc 2003; 57: 178-182
• 3 Soderlund C, Linder S. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc 2006; 63: 986-995
• 4 Kullman E, Frozanpor F, Soderlund C et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc 2010; 72: 915-923
• 5 Isayama H, Komatsu Y, Tsujino T et al. A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction. Gut 2004; 53: 729-734
• 6 Almadi MA, Barkun AN, Martel M. No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction: a meta-analysis. Clin Gastroenterol Hepatol 2013; 11: 27-37 (e21)
• 7 Saleem A, Leggett CL, Murad MH et al. Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction. Gastrointest Endosc 2011; 74: 321-327 (e321 – e323)
• 8 Stoeckel D, Pelton A, Duerig T. Self-expanding nitinol stents: material and design considerations. Eur Radiol 2004; 14: 292-301
• 9 Moss AC, Morris E, Leyden J et al. Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat Rev 2007; 33: 213-221
• 10 Gardner TB. Considering an investment in precious metals?. Time to take stock. Gastrointest Endosc 2010; 72: 755-757
• 11 Moss AC, Morris E, Mac Mathuna P. Palliative biliary stents for obstructing pancreatic carcinoma. Cochrane Database Syst Rev 2006; 25: CD004200
• 12 Isayama H, Mukai T, Itoi T et al. Comparison of partially covered nitinol stents with partially covered stainless stents as a historical control in a multicenter study of distal malignant biliary obstruction: the WATCH study. Gastrointest Endosc 2012; 76: 84-92
• 13 Isayama H, Nakai Y, Toyokawa Y et al. Measurement of radial and axial forces of biliary self-expandable metallic stents. Gastrointest Endosc 2009; 70: 37-44
• 14 Freeman ML. Adverse outcomes of endoscopic retrograde cholangiopancreatography: avoidance and management. Gastrointest Endosc Clin N Am 2003; 13: 775-798, xi
• 15 Lilford R, Braunholtz D, Harris J et al. Trials in surgery. Br J Surg 2004; 91: 6-16
• 16 Barkin JS, Goldstein JA. Diagnostic approach to pancreatic cancer. Gastroenterol Clin North Am 1999; 28: 709-722, xi
• 17 Ahmad J, Siqueira E, Martin J et al. Effectiveness of the Ultraflex Diamond stent for the palliation of malignant biliary obstruction. Endoscopy 2002; 34: 793-796
• 18 Dumonceau JM, Cremer M, Auroux J et al. A comparison of Ultraflex Diamond stents and Wallstents for palliation of distal malignant biliary strictures. Am J Gastroenterol 2000; 95: 670-676
• 19 Telford JJ, Carr-Locke DL, Baron TH et al. A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc 2010; 72: 907-914
• 20 Kahaleh M, Tokar J, Conaway MR et al. Efficacy and complications of covered Wallstents in malignant distal biliary obstruction. Gastrointest Endosc 2005; 61: 528-533
• 21 Gonzalez-Huix F, Huertas C, Figa M et al. A randomized controlled trial comparing the covered (CSEMS) versus uncovered self-expandable metal stents (USEMS) for the palliation of malignant distal biliary obstruction (MDBO): Interim analysis. Gastrointest Endosc 2008; 67: Ab166
• 22 Luigiano C, Ferrara F, Cennamo V et al. A comparison of uncovered metal stents for the palliation of patients with malignant biliary obstruction: nitinol vs stainless steel. Dig Liver Dis 2012; 44: 128-133
• 23 Weston BR, Ross WA, Liu J et al. Clinical outcomes of nitinol and stainless steel uncovered metal stents for malignant biliary strictures: is there a difference?. Gastrointest Endosc 2010; 72: 1195-1200
• 24 Yang KY, Ryu JK, Seo JK et al. A comparison of the Niti-D biliary uncovered stent and the uncovered Wallstent in malignant biliary obstruction. Gastrointest Endosc 2009; 70: 45-51
• 25 Loew BJ, Howell DA, Sanders MK et al. Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: final results of an international multicenter, randomized, controlled trial. Gastrointest Endosc 2009; 70: 445-453
• 26 Park do H, Kim MH, Choi JS et al. Covered versus uncovered wallstent for malignant extrahepatic biliary obstruction: a cohort comparative analysis. Clin Gastroenterol Hepatol 2006; 4: 790-796
• 27 Rossi P, Bezzi M, Salvatori FM et al. Clinical experience with covered wallstents for biliary malignancies: 23-month follow-Up. Cardiovasc Intervent Radiol 1997; 20: 441-447
• 28 Lee JH, Krishna SG, Singh A et al. Comparison of the utility of covered metal stents versus uncovered metal stents in the management of malignant biliary strictures in 749 patients. Gastrointest Endosc 2013; 78: 312-324
• 29 Isayama H, Nakai Y, Kogure H et al. Biliary self-expandable metallic stent for unresectable malignant distal biliary obstruction: which is better: covered or uncovered?. Dig Endosc 2013; 25: 71-74
• 30 Isayama H, Kawabe T, Nakai Y et al. Cholecystitis after metallic stent placement in patients with malignant distal biliary obstruction. Clin Gastroenterol Hepatol 2006; 4: 1148-1153
• 31 Cote GA, Kumar N, Ansstas M et al. Risk of post-ERCP pancreatitis with placement of self-expandable metallic stents. Gastrointest Endosc 2010; 72: 748-754